DoseMeRx is the world’s first (and largest) Bayesian dosing platform. We combine smart technology with science, leveraging clinically-validated pharmacokinetic drug models, patient characteristics, drug concentrations and genotype to accurately individualize a dose in seconds. Spend less time on calculations - and more time on your patients.
Location: United States, New Jersey, Moorestown Township
Employees: 11-50
Phone: +1 832-358-3308
Total raised: $2.6M
Founded date: 2014
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.08.2016 | Series A | $2.6M | - |
Mentions in press and media 1
| Date | Title | Description |
| 03.11.2025 | DoseMe Acquires Firstline | DoseMe, a Jupiter, FL-based company which specializes in model-informed precision dosing (MIPD) software and a portfolio company of Fairlong Capital, acquired Firstline, a Vancouver, Canada-based provider of a clinical decision support plat... |